首页> 外文期刊>Asia-Pacific Biotech News >A road map to achieve competitive position in the global biotech marketplace: Part I - global biotech market overview and opportunity analysis
【24h】

A road map to achieve competitive position in the global biotech marketplace: Part I - global biotech market overview and opportunity analysis

机译:在全球生物技术市场中获得竞争地位的路线图:第一部分-全球生物技术市场概述和机会分析

获取原文
获取原文并翻译 | 示例
           

摘要

Australia's focus on biotechnology began in the 1990s, although this industry has been active in the country since the 1970s. Australia's traditional strengths in medical and agricultural research have helped the country to move up the global biotechvalue-chain in a very short time. The Australian economy is relatively small compared to other biotech behemoths such as the United States and Japan and the government has realized the importance of innovation through industries such as biotechnology toboost the economy. This has translated into generous research funding and a favorable policy atmosphere for the industry, which in turn has grown steadily. The following White Paper builds a global, regional, and country perspective on the biotechnologyindustry and analyzes the competitive position of Australian biotech companies. The White Paper also elucidates key strategies for Australian biotech companies for achieving sustainable growth.
机译:澳大利亚对生物技术的关注始于1990年代,尽管自1970年代以来该行业一直活跃在澳大利亚。澳大利亚在医学和农业研究方面的传统优势帮助该国在很短的时间内向全球生物技术价值链发展。与美国和日本等其他生物技术庞然大物相比,澳大利亚的经济规模相对较小,而且政府已经意识到通过生物技术等行业推动经济创新的重要性。这已经转化为慷慨的研究资金和对该行业有利的政策氛围,而该行业又在稳步增长。以下白皮书建立了生物技术行业的全球,区域和国家观点,并分析了澳大利亚生物技术公司的竞争地位。白皮书还阐明了澳大利亚生物技术公司实现可持续增长的关键策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号